This study is testing a new way to deliver radiation therapy called vGRID SBRT (Stereotactic Body Radiation Treatment) for people with liver cancer (hepatocellular carcinoma or mixed HCC and cholangiocarcinoma) that cannot be removed by surgery or has spread. The goal is to find the highest safe dose of this radiation treatment. You may be able to join if you are 18 or older, have a good performance status (meaning you can perform daily activities), and have confirmed liver cancer. The study will look at how well people tolerate the treatment and any side effects. The current status of the study is unclear, and it plans to enroll 18 participants.

Study design

This is an interventional study with a planned enrollment of 18 participants. It is designed to find the maximum tolerated dose of a single radiation treatment.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, maximum tolerated dose, is measured from the first day after treatment through 3 months post-radiation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.